The Economic Times daily newspaper is available online now.

    Piramal Enterprises shares tank 8% post Q1 results and buyback announcement

    Synopsis

    Piramal Enterprises reported a profit of INR 508.78 crore ($68.65m) in the June quarter compared to INR 8,155.47 crore ($1.1bn) in the same period last year. The earnings saw Piramal's stock plummet 8% to INR 986 in BSE trading. The firm has also revealed plans to buy back up to INR 1,750 crore ($235.7m) worth of shares at a price of INR1,250 ($16.87) per share. Piramal's stock has risen more than 20% this year.

    Piramal Enterprises shares tank 8% post Q1 results and buyback announcementETMarkets.com
    Shares of Piramal Enterprises tanked 8% to Rs 986 in Monday's trade on BSE after the firm reported its June quarter earnings and Rs 1,750 crore share buyback announcement.

    For the June quarter, the company posted a profit of Rs 508.78 crore compared with Rs 8,155.47 crore in the year-ago quarter. The company had recorded an exceptional gain of Rs 7,613.96 crore on demerged Pharma undertakings in the year-ago quarter.

    Its revenue from operations stood at Rs 2,898.97 crore compared with Rs 2,161.28 crore in the same quarter last year.

    The board of Piramal Enterprises also approved a share buyback of up to 1,40,00,000 shares of face value Rs 10 each for an aggregate amount not exceeding Rs 1,750 crore. The firm set the buyback price at Rs 1,250, which is at a 16.5% premium over Friday's closing price of Rs 1,072.8 for the stock.

    The buyback size represents 5.87% of the total paid-up equity share capital of the company.

    At 12.43 pm, the scrip was trading 5.7% lower at Rs 1,012 on BSE. On a year-to-date basis, the stock has surged over 20%.

    Post Q1 results, brokerage firm Emkay retained its Buy rating on Piramal Enterprises with a target price of Rs 1,230.

    "To reflect the Q1 developments, especially goodwill impairment and wholesale assets transition to SR, we change our FY24-26 estimates. Hence, we cut earnings for FY24- 25E. Overall, PIEL seems to be progressing well on its medium-term plan of delivering 3% RoA, and should be assessed over the medium-term outlook, and beyond the near term," Emkay said.

    Meanwhile, brokerage firm Motilal Oswal reiterated its Buy rating on the stock with a target price of Rs 1,260, which indicates an upside potential of 24.5% from the current market price.

    "Over the next two years, we expect the company to make meaningful inroads into Retail, led by mortgages/LAP and complemented by a good mix of unsecured loans. Product diversification within Retail will help PIEL deliver strong growth and reduce concentration risks. We expect PIEL to deliver ~2.1% RoA and 6.3% RoE in FY25E," Motilal said.

    "We acknowledge that PIEL possesses pockets of value - deferred tax assets relating to the time of DHFL acquisition, potential recoveries from written-off exposures, and fee income levers that it can leverage to enhance profitability," it said.

    (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)



    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in